NDT Advance Access originally published online on February 13, 2009
Nephrology Dialysis Transplantation 2009 24(7):2179-2186; doi:10.1093/ndt/gfp035
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit
1 Department of Internal Medicine 2 Department of Medical Biometry, Hannover Medical School, Hannover 3 Department of Internal Medicine, Saarland University Centre, Homburg/Saar, Germany
Correspondence and offprint requests to: Danilo Fliser; E-mail: indfli{at}uks.eu
 |
Abstract |
|---|
Background. Increasing the dose of renal replacement therapy has been shown to improve survival in critically ill patients with acute kidney injury (AKI) in several smaller European trials. However, a very recent large multicentre trial in the USA could not detect an effect of dose of renal replacement therapy on mortality. Based on those studies, it is not known whether a further increase in dialysis dose above and beyond the currently employed doses would improve survival in patients with AKI. We therefore aimed to assess mortality and renal recovery of patients with AKI receiving either standard (SED) or intensified extended dialysis (IED) therapy in the intensive care unit.
Methods. A prospective randomized parallel group study was conducted in seven intensive care units of a tertiary university hospital. Pre-existing chronic kidney disease was an exclusion criterion. A total of 156 patients (570 screened) with AKI requiring renal replacement therapy were randomly assigned to receive standard dialysis [dosed to maintain plasma urea levels between 120 and 150 mg/dL (20–25 mmol/L)] or intensified dialysis [dosed to maintain plasma urea levels <90 mg/dL (<15 mmol/L)]. Outcome measures were survival at Day 14 (primary) and survival and renal recovery at Day 28 (secondary) after initiation of renal replacement therapy.
Results. Treatment intensity differed significantly (P < 0.01 for plasma urea and administered dose). No differences between intensified and standard treatment were seen for survival by Day 14 (70.4% versus 70.7%) or Day 28 (55.6% versus 61.3%), or for renal recovery amongst the survivors by Day 28 (60.0% versus 63.0%).
Conclusions. Although this study cannot deliver a definitive answer, it suggests that increasing the dose of extended dialysis above the currently recommended dose might neither reduce mortality nor improve renal recovery in critically ill patients, mainly septic patients, with AKI.
Keywords: dialysis dose; renal recovery; SLED; survival
* Both authors contributed equally to this study and are considered first authors.
Received for publication: 3. 6.08
Accepted in revised form: 19. 1.09
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Bouchard, E. Macedo, S. Soroko, G. M. Chertow, J. Himmelfarb, T. A. Ikizler, E. P. Paganini, R. L. Mehta, and DM, FACP, FASN. Program to Improve Care in Acute R Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury Nephrol. Dial. Transplant., August 13, 2009; (2009) gfp392v1. [Abstract] [Full Text] [PDF]
|
|